openPR Logo
Press release

Key Trend Reshaping the Sheep And Goat Pox Vaccines Market in 2025: Prophylactic Vaccination Strategies In Animal Health

03-25-2025 07:20 AM CET | Health & Medicine

Press release from: The Business Research Company

Sheep And Goat Pox Vaccines

Sheep And Goat Pox Vaccines

What market dynamics are playing a key role in accelerating the growth of the sheep and goat pox vaccines market?
The growing demand for livestock products is expected to propel the growth of the sheep and goat pox vaccines market. The demand for livestock products is rising due to factors such as population growth, urbanization, and changing consumer preferences. Sheep and goat pox vaccines are essential for preventing disease outbreaks in livestock, ensuring their health and productivity. For example, in February 2024, the UK's Department for Environment, Food, and Rural Affairs reported an increase in red meat production, particularly mutton and lamb, by 2.9%. Therefore, the growing demand for livestock products is driving the growth of the sheep and goat pox vaccines market.

Get Your Sheep And Goat Pox Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/sheep-and-goat-pox-vaccines-global-market-report

How will the growth rate of the sheep and goat pox vaccines market shape industry trends by 2034?
The sheep and goat pox vaccines market has grown steadily in recent years. It is projected to rise from $57.79 billion in 2024 to $60.58 billion in 2025, achieving a CAGR of 4.8%. The growth can be attributed to more frequent outbreaks of the disease, government vaccination programs, advancements in veterinary medicine, high mortality rates in livestock, greater awareness among farmers, and trade restrictions on affected regions.

The sheep and goat pox vaccines market is forecast to reach $72.47 billion by 2029, with a CAGR of 4.6%. Growth is driven by increasing demand for livestock products, expanding livestock farming, government subsidies for vaccines, rising investment in veterinary research, and advancements in vaccine production technology. Key trends include the development of multivalent and recombinant vaccines, increased focus on vaccine safety, public-private partnerships, expansion of veterinary vaccine markets, and digital tracking of vaccination programs.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16533&type=smp

What trends are poised to drive the future success of the sheep and goat pox vaccines market?
Companies in the sheep and goat pox vaccine market are creating live attenuated vaccines to improve immune responses while reducing side effects. For example, in August 2022, the Indian Council of Agricultural Research developed Lumpi-ProVacInd to fight Lumpy Skin Disease (LSD) in cattle. This vaccine offers one-year immunity with a single dose, inducing a robust immune response and requiring careful storage and transportation at 4°C.

Which primary segments of the sheep and goat pox vaccines market are driving growth and industry transformations?
The sheep and goat pox vaccines market covered in this report is segmented -

1) By Type: Live Attenuated Vaccines, Inactivated Vaccines, Other Types
2) By Route Of Administration: Injectable, Intranasal
3) By Application: Sheep, Goat

Subsegments:
1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines
2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines
3) By Other Types: Recombinant Vaccines, DNA-Based Vaccines

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16533

Which geographical regions are pioneering growth in the sheep and goat pox vaccines market?
North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the sheep and goat pox vaccines market landscape?
Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Santé Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16533&type=smp

What Is Covered In The Sheep And Goat Pox Vaccines Global Market Report?

•Market Size Forecast: Examine the sheep and goat pox vaccines market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the sheep and goat pox vaccines market for a structured understanding.
•Key Players Overview: Analyze major players in the sheep and goat pox vaccines market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the sheep and goat pox vaccines market.
•Segment Contributions: Evaluate how different segments drive overall growth in the sheep and goat pox vaccines market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the sheep and goat pox vaccines market.
•Industry Challenges: Identify potential risks and obstacles affecting the sheep and goat pox vaccines market.
•Competitive Landscape: Review strategic developments in the sheep and goat pox vaccines market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Trend Reshaping the Sheep And Goat Pox Vaccines Market in 2025: Prophylactic Vaccination Strategies In Animal Health here

News-ID: 3934947 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,